Latest models for the discovery and development of rheumatoid arthritis drugs

Area of Science:

• Rheumatology
• Immunology
• Biomedical Engineering

Background:

• Rheumatoid arthritis (RA) is a chronic autoimmune disease significantly impacting quality of life.
• Current therapeutic agent development for RA is hindered by inadequate experimental models.
• Existing models often oversimplify human pathogenesis, limiting their predictive value.

Purpose of the Study:

• To review current and advanced models for rheumatoid arthritis (RA) drug development.
• To discuss the advantages and limitations of various experimental approaches.
• To highlight the potential of novel human-based models in accelerating RA research.

Main Methods:

• Review of existing literature on RA models, including cell cultures and animal studies.
• Analysis of two-dimensional (2D) and three-dimensional (3D) cell culture systems.
• Evaluation of tissue engineering and organ-on-a-chip technologies for RA research.

Main Results:

• Traditional 2D cell cultures and animal models have limitations in replicating RA's complexity.
• Advanced models like 3D tissues, bioreactors, and joint-on-a-chip devices offer improved human relevance.
• These novel systems can provide deeper insights into RA's molecular mechanisms.

Conclusions:

• Current RA models require enhancement to reflect patient heterogeneity and disease complexity.
• Advanced, human-centric models are essential for accelerating the identification of new biomarkers and effective treatments.
• Utilizing sophisticated tools like organ-on-a-chip technology promises to revolutionize RA therapeutic development.